Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Prignano

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Dermatology and Therapy|January 23, 2026
Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective StudyTiago Torres, Siddhartha Sood, Orhan Yilmaz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2025
Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective studyYunyun Miao, Alain Beauchet, Maryam Piram, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2025
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative studyTiago Torres, Jensen Yeung, Vimal Prajapati, et al.
The Journal of Investigative Dermatology|December 30, 2024
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis SuppurativaChiara Moltrasio, Ronald Moura, Andrea Conti, et al.
Italian Journal of Dermatology and Venereology|March 9, 2022
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasisPaolo Gisondi, Maria C Fargnoli, Paolo Amerio, et al.
Acta Dermato-Venereologica|April 27, 2021
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME StudyAntonio Costanzo, Filomena Russo, Marco Galluzzo, et al.
Pediatric Dermatology|July 6, 2026
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe CohortAhmad Rached, Yuyun Miao, Alain Beauchet, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Clinical and Experimental Dermatology|July 29, 2025
Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicenter retrospective studyTiago Torres, Siddhartha Sood, Orhan Yilmaz, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Dermatology and Therapy|January 23, 2026
Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective StudyTiago Torres, Siddhartha Sood, Orhan Yilmaz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 17, 2025
Drug survival of systemic treatments for severe paediatric psoriasis: An international retrospective studyYunyun Miao, Alain Beauchet, Maryam Piram, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2025
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative studyTiago Torres, Jensen Yeung, Vimal Prajapati, et al.
The Journal of Investigative Dermatology|December 30, 2024
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis SuppurativaChiara Moltrasio, Ronald Moura, Andrea Conti, et al.
Italian Journal of Dermatology and Venereology|March 9, 2022
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasisPaolo Gisondi, Maria C Fargnoli, Paolo Amerio, et al.
Acta Dermato-Venereologica|April 27, 2021
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME StudyAntonio Costanzo, Filomena Russo, Marco Galluzzo, et al.
Pediatric Dermatology|July 6, 2026
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe CohortAhmad Rached, Yuyun Miao, Alain Beauchet, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Clinical and Experimental Dermatology|July 29, 2025
Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicenter retrospective studyTiago Torres, Siddhartha Sood, Orhan Yilmaz, et al.
Pageof 20